Arlington Corporation's financial statements (dollars and shares are in millions) are provided here.

Balance Sheets as of December 31
	2019		2018
Assets
Cash and equivalents	$ 15,000		$ 13,000
Accounts receivable	35,000		30,000
Inventories	31,025		29,000
Total current assets	$ 81,025		$ 72,000
Net plant and equipment	50,000		49,000
Total assets	$131,025		$121,000
Liabilities and Equity
Accounts payable	$ 10,600		$ 9,000
Accruals	7,400		6,000
Notes payable	6,200		5,300
Total current liabilities	$ 24,200		$ 20,300
Long-term bonds	20,000		20,000
Total liabilities	$ 44,200		$ 40,300
Common stock (4,000 shares)	60,000		60,000
Retained earnings	26,825		20,700
Common equity	$ 86,825		$ 80,700
Total liabilities and equity	$131,025		$121,000

Income Statement for Year Ending December 31, 2019
Sales	$240,000
Operating costs excluding depreciation and amortization	190,000
EBITDA	$ 50,000
Depreciation & amortization	7,000
EBIT	$ 43,000
Interest	5,350
EBT	$ 37,650
Taxes (25%)	9,412.50
Net income	$ 28,237.50
Dividends paid	22,112.50

1. What was Arlington's 2019 EVA? Assume that its after-tax cost of capital is 10%. Round your answer to the nearest cent.

   $ million

2. What was Arlington's MVA at year-end 2019? Assume that its stock price at December 31, 2019 was $25. Round your answer to the nearest cent.

   $ million